Global Cancer Stem Cells Market to Boost with CAGR of 11.8% and Cross a Margin of $1,898.3 Million During the Covid-19 Outbreak – Exclusive Report [150 Pages] by Research Dive
December 08, 2020 09:05 ET
|
Research Dive
New York, USA, Dec. 08, 2020 (GLOBE NEWSWIRE) -- The cancer stem cells market is anticipated to grow rapidly in the Covid-19 outbreak due to usage of cancer stem cells for treating cancer. According...
CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent Announcements for Glioblastoma Multiforme (GBM) Therapy
November 24, 2020 08:00 ET
|
CNS Pharmaceuticals, Inc.
HOUSTON, Nov. 24, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary...
Grey Cloak Tech Inc. Releases Independent Report
October 20, 2020 08:30 ET
|
Grey Cloak Tech Inc.
LAS VEGAS, Oct. 20, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Grey Cloak Tech Inc. (OTC: GRCK) (soon to be Healthy Extracts Inc. pending a corporate name change), a company engaged in proprietary...
CNS Pharmaceuticals and Image Analysis Group Partner to Further the Development of Berubicin
September 24, 2020 08:00 ET
|
CNS Pharmaceuticals, Inc.
HOUSTON, Sept. 24, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel...
BrainBit Launches Demo App with Multiple Meditation Levels, Sleep Stages Analysis
June 15, 2020 07:00 ET
|
BrainBit Inc.
NEW YORK, June 15, 2020 (GLOBE NEWSWIRE) -- BrainBit, Inc, a Silicon Valley and NYC-based tech company specializing in smart wearable IoT devices for sport, wellness and entertainment applications,...
Denali Therapeutics Announces Publication of Two New Papers Describing Its Blood-Brain Barrier Delivery Technology in Science Translational Medicine
May 27, 2020 16:30 ET
|
Denali Therapeutics Inc.
Denali’s “Transport Vehicle” technology enables broad distribution and improved exposure levels of therapeutic proteins throughout the brainClinical proof of concept data with DNL310 (ETV:IDS), the...
Grey Cloak Tech Inc. Announces Acquisition of Ultimate Brain Nutrients
April 14, 2020 08:30 ET
|
Grey Cloak Tech Inc.
LAS VEGAS, April 14, 2020 (GLOBE NEWSWIRE) -- via NetworkWire - Grey Cloak Tech Inc. (OTC: GRCK) (the “Company”) today announces the completion of its acquisition of Ultimate Brain Nutrients, LLC...
Narbis Launches Smart Glasses Using Neurofeedback and NASA-Developed Algorithm to Encourage Practicing Focus and Concentration
October 29, 2019 08:00 ET
|
Narbis
AMBLER, Pa., Oct. 29, 2019 (GLOBE NEWSWIRE) -- Narbis, a technology company dedicated to developing wellness products that encourage practicing focus and concentration, today announced the online...
Leading Medical Institutions Establish Cognitive Training Centers of Excellence
September 17, 2019 08:00 ET
|
Posit Science
SAN FRANCISCO, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Posit Science, the maker of BrainHQ brain exercises and assessments, announced the establishment of Centers of Excellence at three leading medical...
Aptinyx Presents Data Demonstrating Positive Activity of NYX-458 on Cognitive Performance and Biomarkers in a Preclinical Model of Head Injury
August 21, 2019 08:33 ET
|
Aptinyx Inc.
EVANSTON, Ill., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous...